Deciphex an Irish based technology player, applying AI in pathology, has announced the conclusion of a €2.3m equity funding and convertible debt conversion event which will empower the company to accelerate its research and development in Artificial Intelligence and ramp up market entry in preclincial/toxicologic digital pathology.
HBAN will hold the first Food Investor Forum of 2019 on 21st May in Dublin . The half-day event will bring together current HBAN Food Syndicate Investors, other HBAN Investors interested in the food sector and New Investors interested in getting involved in food investing. It will also bring together other key stakeholders in the food industry including Kerry Group, Finistere (a later stage US and Irish Food and Agtech focused VC), and leaders of successful scaled Food companies to share their market insights and experience. A selection of 4 food sector entrepreneurs from across the broad food supply chain (from production, packaging and distribution) will pitch to investors to raise investment.
HBAN, a joint initiative of Enterprise Ireland, InterTradeIreland and Invest Northern Ireland, will host an Introductory Business Angel Investing seminar at the Wexford Chamber Offices, Hill Street, Wexford, Wednesday 8th May from 5.30pm. The seminar will feature a session with seasoned angel investor Brian McDonald and networking opportunities with members of South East Business Angel Network.
Signum Surgical, a company dedicated to developing minimally invasive technologies to treat colorectal diseases, today announced the company has secured €3.6 million ($4 million) through two grant funding awards. The grants include €2.3 million from the European Union Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund (DTIF). Funds from these grants will support regulatory and clinical programs leading to the commercialization of the company’s BioHealxTM device, which is designed to treat anal fistula, a painful colorectal condition that affects one in 5,000 people worldwide.
HBAN Investment Consultant Niamh Sterling spoke with Silicon Republic this week on what Angel Investors are looking for in a start-up, what makes a great entrepreneur and the critical ingrediants to start up success.
CroíValve, a medtech start-up providing a safe and effective treatment for tricuspid regurgitation, today announces that it has secured €3.2 million in an oversubscribed seed financing round. The round was led by the HBAN (Halo Business Angel Network) MedTech and Irrus Syndicates, alongside Atlantic Bridge University Fund, Enterprise Ireland, SOSV and a group of cardiologists who see the treatment’s transformative potential. The funding will support the continued development of CroíValve’s innovative technology.
Do you want to learn more about angel investing?
Do you want to meeting like-minded individuals from your region?
HBAN is committed to supporting the increase in female business angel activity on the island of Ireland and in partnership with ESIL, Enterprise Ireland, the Local Enterprise Offices in Mayo, Galway & Roscommon, West BIC, the Western Development Commission and Empower, delighted to share with you the next event in a series of events aimed to achieve this.
FiBAN has made a new study on the Internal Rate of Return (IRR) of 126 business angel exits in Finland. The IRR results show that the exits made by professional Finnish business angels are very profitable, but the risks are high.
If you‘re a high potential Start Up that has a new innovative product or service ready for commercialisation and/or have achieved some early traction and are raising finance to scale internationally please contact us.